Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
KushTabs
- Development stage
- Preclinical
- Lead developer
- NeutriSci International
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
KushTabs, also known as Dablets, are THC/CBD-infused dissolvable oral tablets developed by NeutriSci International. These tablets leverage NeutriSci's proprietary technology and ingredients for their formulation. Cryopharm holds exclusive rights to manufacture and distribute KushTabs, initially in California and Nevada, with plans for expansion into Washington and Oklahoma. The product is designed to deliver the effects of both Tetrahydrocannabinol (THC) and Cannabidiol (CBD) through oral administration. THC is the primary psychoactive component of cannabis, acting as a partial agonist on cannabinoid receptors CB1 and CB2, which are involved in mood, memory, pain, and immune function. CBD, a non-psychoactive cannabinoid, has a more complex pharmacology, including indirect modulation of CB1 and CB2 receptors, and interaction with various other non-cannabinoid receptors and ion channels, contributing to its potential therapeutic effects.
- Brand names
- KushTabsDablets
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on KushTabs.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on KushTabs.